• PEI-Laminarin Nanoparticles as Vaccine Adjuvants

  2026-08-31

  The reference study develops polyethyleneimine-modified Laminarin nanoparticles that combine a cationic polysaccharide carrier with ovalbumin to improve dendritic-cell uptake, lysosomal escape, antigen cross-presentation, and adaptive immunity. Its findings support surface-charge engineering as a practical strategy for linking nanoparticle design with stronger humoral and cellular responses than an aluminum-adjuvant comparison.

• CGP 55845 Hydrochloride in GABAB Assays

  2026-08-31

  CGP 55845 hydrochloride provides a selective pharmacological control for separating GABAB receptor signaling from astrocytic GAT-3 effects in dentate gyrus experiments. Its value is greatest in paired electrophysiology, optogenetic, calcium-imaging, and neurotransmitter-release workflows where receptor-dependent and transporter-dependent mechanisms must be distinguished.

• Ibotenic Acid in Circuit Neuroscience Workflows

  2026-08-30

  Ibotenic acid is an NMDA receptor agonist for controlled glutamatergic perturbation, focal excitotoxicity studies, and preclinical neurodegenerative disease models. This workflow-focused guide explains how to prepare the compound, separate lesion effects from circuit-specific mechanisms, and use behavioral, molecular, and histological readouts to improve interpretation.

• How NINJ1 Rings Drive Plasma Membrane Rupture

  2026-08-29

  The reference study proposes that NINJ1 promotes plasma membrane rupture by assembling into membrane-associated, nanodisc-like rings rather than acting only as a conventional adhesion protein. Combining cryo-EM, liposome reconstitution, live-cell imaging, and super-resolution microscopy, the authors distinguish NINJ1 from NINJ2 and connect ring formation with inflammasome-associated cell lysis.

• PreScission Protease (PSP): Tag Cleavage Guide

  2026-08-28

  PreScission Protease (PSP), SKU K1101, provides sequence-directed removal of compatible affinity tags from recombinant fusion proteins while supporting cold purification workflows. It is appropriate when the target construct contains an accessible HRV 3C protease cleavage site, but it should not be treated as a universal protease for proteins lacking the required sequence or for workflows with unvalidated buffer compatibility.

• BAPTA: Causal Calcium Signaling in Cell Assays

  2026-08-28

  BAPTA is a high-affinity calcium chelator for testing whether intracellular Ca2+ changes drive apoptosis and pathway activation. This article presents a causal-inference framework grounded in recent IP3R/Ca2+/STAT3 toxicology research, with assay controls, interpretation guidance, and product-handling considerations.

• Tivozanib (AV-951) Assay Workflow Guide

  2026-08-27

  Tivozanib (AV-951) gives oncology researchers a highly selective way to interrogate VEGFR signaling, angiogenesis-related phenotypes, and combination responses. This guide translates its potency and solubility profile into practical dose–response, viability, apoptosis, and troubleshooting workflows.

• Ciprofloxacin Hydrochloride: From Target to Translation

  2026-08-27

  Ciprofloxacin hydrochloride is more than a familiar fluoroquinolone antibiotic: it is a mechanistically defined research tool for studying bacterial DNA replication, immune signaling, and cell-fate responses. This thought-leadership guide connects its validated antibacterial role with emerging anti-parasitic evidence while defining the controls, limitations, and translational decisions needed to move beyond a conventional product-page view.

• Individual SGLT2 Inhibitors in T2D and Heart Failure

  2026-08-26

  This systematic review and network meta-analysis compared five SGLT2 inhibitors in 20,438 patients with type 2 diabetes and heart failure, separating class-wide effects from possible differences between individual drugs. All agents reduced heart failure hospitalization, whereas the composite of cardiovascular death or hospitalization showed a less uniform pattern, providing a more cautious framework for interpreting ertugliflozin evidence.

• Reversine: Practical Aurora Kinase Inhibitor Guide

  2026-08-26

  Reversine (SKU A3760) is a research small molecule for probing Aurora kinase-dependent mitotic regulation, cell-cycle disruption, and related cancer phenotypes. This guide covers stock preparation, assay controls, and interpretation boundaries; it is intended for laboratory research only, not diagnosis, treatment, or clinical use.

• Oligo (dT) 25 Beads: Practical mRNA Purification

  2026-08-25

  Oligo (dT) 25 Beads support selective eukaryotic mRNA isolation from total RNA or animal and plant cell or tissue preparations through polyA tail mRNA capture. They are not a universal total-RNA cleanup reagent and are unsuitable when the target RNA lacks a polyadenylated tail.

• PERK-Dependent Pyroptosis in Disc Degeneration

  2026-08-25

  This study identifies a mechanistic link between unresolved endoplasmic reticulum stress and pyroptosis in nucleus pulposus cells, placing the PERK/eIF2α/ATF4 axis upstream of JAK1–STAT3 activation. Its findings clarify how ER stress may amplify inflammatory cell death during intervertebral disc degeneration and provide a rationale for testing pathway-specific interventions.

• Ginsenoside Rg1 and Anesthesia-Induced Neuroimmune Injury

  2026-08-24

  A 2025 Journal of Ethnopharmacology study shows that Ginsenoside Rg1 reduces behavioral, inflammatory, synaptic, and intestinal abnormalities caused by prolonged isoflurane anesthesia in mice. Its key mechanistic contribution is evidence that regulatory T cells are required for restoring the gut-immune-brain axis, although translation beyond this preclinical model remains uncertain.

• Bestatin (Ubenimex): Aminopeptidase Inhibitor Guide

  2026-08-24

  Bestatin, also called Ubenimex, is a research inhibitor of aminopeptidase B, leucine aminopeptidase, aminopeptidase N, and related cytosolic aminopeptidases. Its reported nanomolar-to-micromolar IC50 values support aminopeptidase activity measurement, apoptosis assay design, multidrug resistance (MDR) research, and cancer research, but assay conditions and translational limits must be defined.

• Astrocytic GAT-3 in Dentate Gyrus Memory

  2026-08-23

  The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than a passive GABA-clearance mechanism. By linking GABA uptake to astrocytic Ca2+ signaling, presynaptic GluN2B-containing NMDARs, and contextual fear memory, it provides a mechanistic framework for studying glia-dependent plasticity in hippocampal circuits.

8535 records 3/569 page Previous Next 12345 下5页 Last page